Annual Report & Accounts

RNS Number : 3973M

Immupharma PLC

06 May 2015

 

6 MAY 2015

ImmuPharma

ANNUAL REPORT AND ACCOUNTS

NOTICE OF ANNUAL GENERAL MEETING:  29 MAY 2015

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2014 will be posted to shareholders today.

The Annual Report will be available later today, in electronic form, for download on the Company's website www.immupharma.org.

The Company's Annual General Meeting will be held on Friday 29 May 2015 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

 For further information please contact:

ImmuPharma plc	+ 44 (0) 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Dr Robert Zimmer, President and Chief Scientific Officer
Franco di Muzio, Interim Chairman
Tracy Weimar, Vice President, Operations and Finance
Lisa Baderoon, Head of Investor Relations	+ 44 (0) 7721 413496
Panmure Gordon (UK) Limited, NOMAD & Broker	[phone]
Hugh Morgan, Fred Walsh, Duncan Monteith, Corporate Finance Charles Leigh-Pemberton, Corporate Broking

 

END

 

 

ACSUGUPCAUPAGCQ